At TheWell Bioscience, we believe every person is unique and personalized medicine can improve the quality of life for every patient. We focus on driving advanced biomedicine with our next-generation xeno-free extracellular matrix (ECM) to drive 3D biomimicking platforms for precision medicine, cell therapy, and biomanufacturing. As a pioneer of a robust xeno-free 3D cell matrix (VitroGel® and VitroINK®), we mimic the natural extracellular matrix for in vitro and in vivo 3D organotypic culture. By working with scientists from academia, hospitals, and pharma industries, we aim to improve biomedicine for patients worldwide. Learn how our ready-to-use and tunable xeno-free hydrogels and bioinks enable 3D cell culture, bioprinting, and cell delivery for researchers in over 50 countries and over 250 universities and research institutes.